Daptomycin (marketed as Cubicin) Information
Cubicin (daptomycin) is indicated for the following infections:
- Complicated skin and skin structure infections (cSSSI)
- Staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis
To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.